ストックスクリーナーアプリを入手
44.23
4.05%
1.72
アフターアワーズ：
44.40
0.17
+0.38%
前日終値:
$42.51
開ける：
$44.29
24時間の取引高:
1.54M
Relative Volume:
1.46
時価総額：
$3.96B
収益：
$900.66M
当期純損益:
$-453.20M
株価収益率:
-7.4461
EPS:
-5.94
ネットキャッシュフロー:
$-274.19M
1週間 パフォーマンス:
-11.45%
1か月 パフォーマンス:
+3.46%
6か月 パフォーマンス:
-0.11%
1年 パフォーマンス:
+42.45%
1日の値動き範囲:
$43.95
$46.03
1週間の範囲:
$35.95
$46.03
52週間の値動き範囲:
$28.72
$58.38
Ptc Therapeutics Inc Stock (PTCT) Company Profile
名前
Ptc Therapeutics Inc
セクター
電話
(908) 222-7000
住所
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ
PTCT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PTCT
Ptc Therapeutics Inc
|
44.23 | 3.96B | 900.66M | -453.20M | -274.19M | -5.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Ptc Therapeutics Inc Stock (PTCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-05-07 | アップグレード | Citigroup | Sell → Neutral |
| 2025-03-11 | アップグレード | BofA Securities | Underperform → Neutral |
| 2025-03-07 | 開始されました | Scotiabank | Sector Perform |
| 2024-12-13 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-03 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-09-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-08-26 | 再開されました | UBS | Buy |
| 2024-05-20 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2023-12-19 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-10-30 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-10-27 | ダウングレード | Citigroup | Neutral → Sell |
| 2023-10-06 | ダウングレード | Truist | Buy → Hold |
| 2023-09-18 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-09-15 | ダウングレード | Raymond James | Outperform → Underperform |
| 2023-03-17 | 開始されました | SVB Securities | Market Perform |
| 2022-12-14 | 開始されました | Goldman | Sell |
| 2022-09-12 | 開始されました | Jefferies | Buy |
| 2022-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-09-01 | 開始されました | Citigroup | Buy |
| 2022-04-04 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-10-18 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-04-26 | 再開されました | Credit Suisse | Neutral |
| 2021-03-29 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2021-02-12 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-01-05 | アップグレード | Citigroup | Neutral → Buy |
| 2020-11-30 | ダウングレード | RBC Capital Mkts | Sector Perform → Underperform |
| 2020-10-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-08-25 | 開始されました | Raymond James | Outperform |
| 2020-04-09 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-20 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-02-20 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-05-13 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-04-11 | 開始されました | Bernstein | Outperform |
| 2018-10-03 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2018-10-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-07-19 | 開始されました | Credit Suisse | Outperform |
| 2018-06-18 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-04-04 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2018-01-29 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2017-11-16 | アップグレード | JP Morgan | Underweight → Neutral |
| 2017-10-26 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Ptc Therapeutics Inc (PTCT) 最新ニュース
PTC Therapeutics, Inc. (PTCT): Among Billionaire David E. Shaw’s Small-Cap Stock Picks with Huge Upside Potential - Insider Monkey
Driehaus Capital Management LLC Makes New $46.99 Million Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
AQR Capital Management LLC Sells 32,230 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Raised to Strong-Buy at StockNews.com - Defense World
Leerink Partnrs Issues Optimistic Outlook for PTCT Earnings - Defense World
William Blair Boosts Earnings Estimates for PTC Therapeutics - Defense World
JPMorgan Chase & Co. Cuts PTC Therapeutics (NASDAQ:PTCT) Price Target to $67.00 - Defense World
PTC Therapeutics (NASDAQ:PTCT) Upgraded at Citigroup - Defense World
Tudor Investment Corp ET AL Increases Stock Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics projects $650M to $800M revenue for 2025 amid global SUFIANCE launch preparations - MSN
PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lost Money on PTC Therapeutics, Inc. (PTCT)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Shareholders Who Lost Money on PTC Therapeutics, Inc. (PTCT) Should Contact Levi & Korsinsky About Securities Fraud InvestigationPTCT - ACCESS Newswire
B of A Securities Upgrades PTC Therapeutics (PTCT) - Nasdaq
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up Following Earnings Beat - MarketBeat
Cantor Fitzgerald Cuts PTC Therapeutics (NASDAQ:PTCT) Price Target to $112.00 - MarketBeat
BofA Upgrades PTC Therapeutics to Buy From Neutral, Adjusts Price Target to $68 From $55 - marketscreener.com
PTC Therapeutics (NASDAQ:PTCT) Price Target Lowered to $67.00 at JPMorgan Chase & Co. - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Raised to Neutral at Citigroup - MarketBeat
Baker BROS. Advisors LP Takes Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics (PTCT) Receives Upgrade from BofA with New Price Target | PTCT Stock News - GuruFocus
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up on Strong Earnings - Defense World
PTCT: Barclays Lowers Price Target for PTC Therapeutics to $42 | PTCT Stock News - GuruFocus
ATTENTION PTCT SHAREHOLDERS: Investors who lost money on PTC Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire
PTC Therapeutics, Inc. (PTCT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call Transcript - Insider Monkey
PTCT: Barclays Reduces Price Target for PTC Therapeutics | PTCT Stock News - GuruFocus
Blackstone Inc. Cuts Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data - Seeking Alpha
Schonfeld Strategic Advisors LLC Has $5.52 Million Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics: Q1 Earnings Snapshot - Norwalk Hour
Price T Rowe Associates Inc. MD Cuts Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTCT: Baird Adjusts Price Target for PTC Therapeutics | PTCT Stock News - GuruFocus
PTCT Analyst Raises Price Target Amid Outperform Rating | PTCT Stock News - GuruFocus
PTC Therapeutics (NASDAQ:PTCT) Shares Gap DownHere's What Happened - MarketBeat
Earnings call transcript: PTC Therapeutics beats Q1 2025 revenue forecast By Investing.com - Investing.com UK
PTC Therapeutics (PTCT) Target Price Adjusted by Cantor Fitzgerald | PTCT Stock News - GuruFocus
PTC Therapeutics to Participate at Upcoming Investor Conferences - Seeking Alpha
PTC Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by PTC Therapeutics, Inc. (PTCT) - ACCESS Newswire
PTC Therapeutics (PTCT) Price Target Lowered by JP Morgan | PTCT Stock News - GuruFocus
PTC Therapeutics upgraded by Citigroup with a new price target - Quantisnow
PTCT Stock Target Price Adjusted by Baird Analyst | PTCT Stock News - GuruFocus
Citigroup Upgrades PTC Therapeutics (PTCT) - Nasdaq
This Logitech International Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
JPMorgan Adjusts Price Target for PTC Therapeutics (PTCT) | PTCT Stock News - GuruFocus
Citigroup Upgrades PTC Therapeutics to Neutral From Sell, Adjusts Price Target to $40 From $50 - marketscreener.com
48,728 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Bought by Raymond James Financial Inc. - MarketBeat
PTC Therapeutics Swings to Q1 Earnings, Revenue Increases - marketscreener.com
PTC Therapeutics Inc (PTCT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
PTC Therapeutics Inc (PTCT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Decoding PTC Therapeutics Inc (PTCT): A Strategic SWOT Insight - GuruFocus
Ptc Therapeutics Inc (PTCT) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):